KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Hims & Hers Health (HIMS) Shares Outstanding (Weighted Average) (2019 - 2026)

Hims & Hers Health's Shares Outstanding (Weighted Average) history spans 8 years, with the latest figure at $228.4 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 2.87% to $228.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $228.4 million, a 2.87% increase, with the full-year FY2025 number at $225.0 million, up 4.18% from a year prior.
  • Shares Outstanding (Weighted Average) hit $228.4 million in Q1 2026 for Hims & Hers Health, up from $225.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for HIMS hit a ceiling of $228.4 million in Q1 2026 and a floor of $202.7 million in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $213.8 million across 5 years, with a median of $213.5 million in 2024.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): surged 32.41% in 2022 and later rose 2.19% in 2023.
  • Tracing HIMS's Shares Outstanding (Weighted Average) over 5 years: stood at $204.5 million in 2022, then increased by 2.36% to $209.3 million in 2023, then grew by 3.15% to $215.9 million in 2024, then rose by 4.18% to $225.0 million in 2025, then rose by 1.51% to $228.4 million in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for HIMS at $228.4 million in Q1 2026, $225.0 million in Q4 2025, and $226.3 million in Q3 2025.